National Research Corp
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, em… Read more
National Research Corp (NRC) - Total Liabilities
Latest total liabilities as of December 2025: $120.89 Million USD
Based on the latest financial reports, National Research Corp (NRC) has total liabilities worth $120.89 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
National Research Corp - Total Liabilities Trend (1993–2025)
This chart illustrates how National Research Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
National Research Corp Competitors by Total Liabilities
The table below lists competitors of National Research Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nanjing Baose Co Ltd
SHE:300402
|
China | CN¥925.74 Million |
|
Hichain Logistics Co Ltd
SHE:300873
|
China | CN¥1.51 Billion |
|
Savers Value Village, Inc.
NYSE:SVV
|
USA | $1.55 Billion |
|
Health and Happiness (H&H) International Holdings Limited
F:8BI
|
Germany | €13.39 Billion |
|
Otc Markets Group
OTCQX:OTCM
|
USA | $48.41 Million |
|
Zhejiang Yasha Decoration Co Ltd
SHE:002375
|
China | CN¥13.51 Billion |
|
Hana Materials Inc
KQ:166090
|
Korea | ₩207.70 Billion |
Liability Composition Analysis (1993–2025)
This chart breaks down National Research Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 8.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.90 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how National Research Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for National Research Corp (1993–2025)
The table below shows the annual total liabilities of National Research Corp from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $120.89 Million | +19.39% |
| 2024-12-31 | $101.25 Million | +37.80% |
| 2023-12-31 | $73.48 Million | +25.77% |
| 2022-12-31 | $58.43 Million | -19.08% |
| 2021-12-31 | $72.20 Million | +4.48% |
| 2020-12-31 | $69.11 Million | -11.16% |
| 2019-12-31 | $77.79 Million | -12.20% |
| 2018-12-31 | $88.60 Million | +137.70% |
| 2017-12-31 | $37.27 Million | -1.44% |
| 2016-12-31 | $37.82 Million | -31.09% |
| 2015-12-31 | $54.88 Million | +31.40% |
| 2014-12-31 | $41.76 Million | +6.42% |
| 2013-12-31 | $39.24 Million | -9.38% |
| 2012-12-31 | $43.30 Million | -4.03% |
| 2011-12-31 | $45.12 Million | -4.06% |
| 2010-12-31 | $47.03 Million | +66.03% |
| 2009-12-31 | $28.33 Million | -11.61% |
| 2008-12-31 | $32.05 Million | +63.67% |
| 2007-12-31 | $19.58 Million | -20.98% |
| 2006-12-31 | $24.78 Million | +105.11% |
| 2005-12-31 | $12.08 Million | -6.60% |
| 2004-12-31 | $12.94 Million | -2.36% |
| 2003-12-31 | $13.25 Million | +22.52% |
| 2002-12-31 | $10.81 Million | +3.79% |
| 2001-12-31 | $10.42 Million | +1.60% |
| 2000-12-31 | $10.26 Million | -4.16% |
| 1999-12-31 | $10.70 Million | +20.22% |
| 1998-12-31 | $8.90 Million | +97.78% |
| 1997-12-31 | $4.50 Million | +9.76% |
| 1996-12-31 | $4.10 Million | +29.50% |
| 1995-12-31 | $3.17 Million | +65.24% |
| 1994-12-31 | $1.92 Million | +77.74% |
| 1993-12-31 | $1.08 Million | -- |